Published financial brief
3NFSPF
SINOVAC BIOTECH LTD
- As of
- 2023-12-31
- Source
- Supabase fundamentals
- Calculator
- financial-roic-1.0.0
- Published
- 7/26/2026
2 data notes
- Input provenance requires review.
- One or more values are unavailable.
Exact-period record
Fundamentals
5 reported periods
| Metric | FY 20192019-12-31 | FY 20202020-12-31 | FY 20212021-12-31 | FY 20222022-12-31 | FY 20232023-12-31 |
|---|---|---|---|---|---|
| Financial statements | |||||
| RevenueUSD millions | 246.1 | 510.6 | 19,375 | 1,492.8 | 448.3 |
| Cost of goods soldUSD millions | 27.7 | 63.1 | 985.4 | 527.9 | 36.8 |
| Selling, general and administrative expenseUSD millions | 145.4 | 227.9 | 749.2 | 1,269.9 | 813.5 |
| Depreciation and amortizationUSD millions | 4.8 | 4 | 86.8 | 156.6 | 144.8 |
| Net incomeUSD millions | 44.9 | 110.4 | 8,467.5 | 113.9 | -99.9 |
| Operating profit (EBIT)USD millions | 68.2 | 215.5 | 17,554 | -461.6 | -546.7 |
| Income taxesUSD millions | 5.6 | 31.4 | 3,104.1 | -62.9 | 105.3 |
| Short-term debtUSD millions | 13.1 | 42.6 | 15.1 | 10.6 | 81.9 |
| Long-term debtUSD millions | 7.2 | 93.8 | 129.8 | 64 | 217.1 |
| Cash and equivalentsUSD millions | 206.2 | 1,185.5 | 13,426 | 11,321 | 11,228 |
| ReceivablesUSD millions | 113.7 | 253.5 | 952.4 | 609.5 | 450.7 |
| InventoryUSD millions | 27.8 | 105.8 | 375.5 | 180.7 | 139.9 |
| PayablesUSD millions | 5.8 | 30.5 | 58.6 | 19.8 | 17.3 |
| Net property, plant and equipmentUSD millions | 80.9 | 284.2 | 1,018.7 | 1,052.4 | 1,025.1 |
| Capital expenditureUSD millions | 10.6 | 127.5 | 719.8 | 393.8 | 144.5 |
| Operating cash flowUSD millions | 39.1 | 479.3 | 15,353 | -770.8 | 104 |
| Prepaid expensesUSD millions | —missing | —missing | —missing | —missing | —missing |
| AccrualsUSD millions | 43.1 | 164.7 | 866.4 | 810.6 | 897.2 |
| EBITDAUSD millions | 73 | 219.6 | 17,640 | -305 | -402 |
| Working capitalUSD millions | 262.4 | 880.7 | 12,502 | 11,035 | 10,683 |
| Working capital requirementUSD millions | 135.8 | 328.8 | 1,269.3 | 770.4 | 573.3 |
| Total debtUSD millions | 20.3 | 136.4 | 144.9 | 74.7 | 299 |
| Free cash flowUSD millions | 28.4 | 351.8 | 14,633 | -1,164.5 | -40.5 |
| Unlevered free cash flowUSD millions | 18.2 | -132.2 | 12,878 | -199.9 | -349.4 |
| Returns and ratios | |||||
| ROICratio | 27.9% | 29.6% | 620.4% | -24.3% | -32.7% |
| Pre-tax ROICratio | 30.3% | 34.6% | 753.6% | -24.3% | -32.7% |
| Effective tax rateratio | 7.9% | 14.5% | 17.7% | 0% | 0% |
| Revenue growthratio | 7.1% | 107.5% | 3,694.4% | -92.3% | -70% |
| EBIT / Revenueratio | 27.7% | 42.2% | 90.6% | -30.9% | -122% |
| Revenue / Invested capitalmultiple | 1.1× | 0.82× | 8.32× | 0.78× | 0.27× |
| Cogs Over Revenuesratio | 11.2% | 12.4% | 5.1% | 35.4% | 8.2% |
| Sga Over Revenuesratio | 59.1% | 44.6% | 3.9% | 85.1% | 181.5% |
| Da Over Revenuesratio | 2% | 0.8% | 0.4% | 10.5% | 32.3% |
| Nfa Over Revenuesratio | 32.9% | 55.7% | 5.3% | 70.5% | 228.7% |
| Wcr Over Revenuesratio | 55.2% | 64.4% | 6.6% | 51.6% | 127.9% |
| Debt Over Ebitdamultiple | 0.28× | 0.62× | 0.01× | —missing | —missing |
| St Debt Over Cashmultiple | 0.06× | 0.04× | 0× | 0× | 0.01× |
| Interest Over Ebitdamultiple | 0.01× | 0.01× | 0× | —missing | —missing |
| Interest Over Nocf Nicfmultiple | 0.03× | 0× | 0× | -0× | -0.06× |
| Nsf Over Wcrmultiple | -1.42× | -3.48× | -10.57× | -14.68× | -19.44× |
Ask this snapshot
Research assistant
3NFSPF · annualSnapshot 27e8e86f
Answers use only this published snapshot. The assistant will say when the data is insufficient and does not create forecasts, scenarios, or investment advice.
0 / 2,000